Arteriosclerosis Clinical Trial
Official title:
The Clinical Research of Low Intensity Continuous Ultrasonic on Lower Limb Arteriosclerosis Occlusion(ASO) Syndrome
In the present study, by evaluating the efficacy and safety of low intensity ultrasonic on ASO, to explore the noninvasive auxiliary treatment of ASO. 90 patients were randomly divided into 2 groups: A)control group, patients were given Conventional conservative treatment; B)treatment group, patients were given Conventional conservative treatment and low intensity ultrasonic treatment ; Treatments last for 4 weeks, three times a week, stimulation was given 8 minutes every time, location of treatment were lower limb ischemia area and its surrounding tissues; outcome indicators were recorded Before and 4 weeks after the trial, The Walking Impairment Questionnaire (WIQ), ankle brachial ratio, the farthest distance Walking, percutaneous tissue oxygen tension, tissue oxygenation index recovery time, local skin temperature, ultrasonic blood vessels, and muscle enzymes, hepatic and kidney function.
Ultrasound is a form of sound whose frequency is higher than the natural audible range for
humans (> 20 kHz) and ultrasonography has been widely used as diagnostic devices for several
decades. In addition to diagnostic purposes, ultrasound is clinically used for therapeutic
applications, including tumor ablation, thrombolysis, bone regeneration, and facilitated
drug delivery. Recently, therapeutic angiogenic effects of low-intensity ultrasound have
been reported in endothelial cells, chick chorioallantoic membrane, and a rat model of hind
limb ischemia. the investigators hypothesis low-intensity ultrasound can improve the ailment
of ASO. In the present study, by evaluating the efficacy and safety of low intensity
ultrasonic on ASO, to explore the noninvasive auxiliary treatment of ASO. 90 patients were
randomly divided into 2 groups: A)control group,patients were given Conventional
conservative treatment: B)treatment group,patients were given Conventional conservative
treatment and low intensity ultrasonic treatment; Treatments last for 4 weeks, three times a
week, stimulation was given 8 minutes every time, location of treatment were lower limb
ischemia area and its surrounding tissues;outcome indicators were recorded Before and 4
weeks after the trial, The Walking Impairment Questionnaire (WIQ), ankle brachial ratio, the
farthest distance Walking, percutaneous tissue oxygen tension, tissue oxygenation index
recovery time, local skin temperature, ultrasonic blood vessels, and muscle enzymes, hepatic
and kidney function.
the investigators speculate after 4 weeks of Low intensity ultrasonic treatment, all the
observation index of ASO patients can be improved; meanwhile, creatine kinase, liver and
kidney function, blood in urine routine, electrocardiogram (ecg) has no obvious change.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Completed |
NCT02510547 -
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
|
Phase 4 | |
Completed |
NCT02264717 -
Dan-NICAD - Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease
|
N/A | |
Completed |
NCT01334268 -
RESOLUTE China RCT
|
N/A | |
Active, not recruiting |
NCT00154180 -
Kronos Early Estrogen Prevention Study (KEEPS)
|
Phase 4 | |
Recruiting |
NCT04343209 -
Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP)
|
||
Not yet recruiting |
NCT06039748 -
Angiography-Derived Quantitative Functional Assessment Versus Pressure-Derived FFR and IMR: The FAIR Study
|
||
Recruiting |
NCT04142021 -
Safety and Feasibility Evaluation of Planning and Execution of Surgical Revascularization Solely Based on Coronary CTA and FFRCT in Patients With Complex Coronary Artery Disease (FASTTRACK CABG)
|
||
Recruiting |
NCT06008756 -
MK-0616 (Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes
|
Phase 3 | |
Completed |
NCT03253692 -
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
|
||
Active, not recruiting |
NCT04624854 -
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)
|
Phase 4 | |
Active, not recruiting |
NCT02921230 -
Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery
|
N/A | |
Recruiting |
NCT01774058 -
The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation
|
Phase 2 | |
Terminated |
NCT01462721 -
The eSVS® Mesh Randomized Post-Market Study
|
N/A | |
Completed |
NCT01455974 -
The Effects of Lowering Dialysate Sodium in Hypertensive Hemodialysis Patients
|
N/A | |
Completed |
NCT01221610 -
BIOLUX P-I First in Man Study
|
N/A | |
Active, not recruiting |
NCT00174902 -
The Effect of Beta-Blockers and Aspirin on Hemostasis and Endothelial Function After Acute Mental Stress
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT00863967 -
Early Detection of Arteriosclerosis
|
N/A | |
Completed |
NCT00050817 -
Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)
|
Phase 3 | |
Terminated |
NCT02601664 -
Randomized-controlled Trial of a Combined vs. Conventional Percutaneous Intervention for Near-Infrared Spectroscopy Defined High-Risk Native Coronary Artery Lesions
|
Phase 4 |